Omission of Breast Surgery in Predicted Pathologic Complete Response after Neoadjuvant Systemic Therapy: A Multicenter, Single-Arm, Non-inferiority Trial
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- KCISCIEScopus
- 저널 순위
- JCR Q3Scopus Q3KCI Q2
- 저널
- JOURNAL OF BREAST CANCER27(1) · pp.61 · 2024
- 피인용
- Web of Science 27Scopus 29KCI 1
- FWCI (Scopus)
- 2.82
- JCR IF
- JCR 2023 2.2
- ISSN
- 1738-6756
저자
- 정지정제1저자Seoul Natl Univ, Dept Surg, Coll Med, 101 Daehak Ro, Seoul 03080, South Korea
- 천종호Seoul Natl Univ, Dept Surg, Seoul Metropolitan Govt, Boramae Med Ctr, Seoul, South Korea
- 김수연Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea
- 고지원Seoul Natl Univ, Coll Med, Dept Pathol, Seoul, South Korea
- 유재민Sungkyunkwan Univ, Samsung Med Ctr, Dept Surg, Div Breast Surg,Sch Med, Seoul, South Korea
- Yoo, Tae-KyungUniv Ulsan, Asan Med Ctr, Dept Surg, Coll Med, Seoul, South Korea
- 신희철Seoul Natl Univ, Dept Surg, Bundang Hosp, Seongnam, South Korea
- 안성귀Yonsei Univ, Gangnam Severance Hosp, Dept Surg, Coll Med, Seoul, South Korea
- 박세호Yonsei Univ, Severance Hosp, Dept Surg, Coll Med, Seoul, South Korea
- 임우성Ewha Womans Univ, Coll Med, Dept Surg, Seoul, South Korea
- 남상은Konkuk Univ, Sch Med, Dept Surg, Med Ctr, Seoul, South Korea
- 박민호Chonnam Natl Univ, Med Sch, Dept Surg, Hwasun Hosp, Hwasun, South Korea
- 김구상Kosin Univ, Gospel Hosp, Dept Breast Surg, Coll Med, Pusan, South Korea
- 강태우Pusan Natl Univ, Sch Med, Dept Surg, Pusan, South Korea
- 이지연Kyungpook Natl Univ, Chilgok Hosp, Sch Med, Dept Surg, Daegu, South Korea
- 윤현조Jeonbuk Natl Univ, Dept Surg, Med Sch, Jeonju, South Korea
- 김유석Chosun Univ, Dept Surg, Coll Med, Gwangju, South Korea
- 윤창익Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Div Breast Surg,Dept Surg, Seoul, South Korea
- 김홍규Seoul Natl Univ Hosp, Biomed Res Inst, Seoul, South Korea
- 문형곤Seoul Natl Univ, Dept Surg, Coll Med, 101 Daehak Ro, Seoul 03080, South Korea
- 한원식Seoul Natl Univ, Dept Surg, Coll Med, 101 Daehak Ro, Seoul 03080, South Korea
- 조나리야Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea
- 김민균교신저자Chung Ang Univ, Coll Med, Dept Surg, Chung Ang Univ Hosp, Seoul, South Korea
- 이한별교신저자Seoul Natl Univ, Dept Surg, Coll Med, 101 Daehak Ro, Seoul 03080, South Korea
초록
Purpose Advances in chemotherapeutic and targeted agents have increased pathologic complete response (pCR) rates after neoadjuvant systemic therapy (NST). Vacuum-assisted biopsy (VAB) has been suggested to accurately evaluate pCR. This study aims to confirm the non-inferiority of the 5-year disease-free survival of patients who omitted breast surgery when predicted to have a pCR based on breast magnetic resonance imaging (MRI) and VAB after NST, compared with patients with a pCR who had undergone breast surgery in previous studies. Methods The Omission of breast surgery for PredicTed pCR patients wIth MRI and vacuum-assisted bIopsy in breaST cancer after neoadjuvant systemic therapy (OPTIMIST) trial is a prospective, multicenter, single-arm, non-inferiority study enrolling in 17 tertiary care hospitals in the Republic of Korea. Eligible patients must have a clip marker placed in the tumor and meet the MRI criteria suggesting complete clinical response (post-NST MRI size ≤ 1 cm and lesion-to-background signal enhancement ratio ≤ 1.6) after NST. Patients will undergo VAB, and breast surgery will be omitted for those with no residual tumor. Axillary surgery can also be omitted if the patient was clinically node-negative before and after NST and met the stringent criteria of MRI size ≤ 0.5 cm. Survival and efficacy outcomes are evaluated over five years. Discussion This study seeks to establish evidence for the safe omission of breast surgery in exceptional responders to NST while minimizing patient burden. The trial will address concerns about potential undertreatment due to false-negative results and recurrence as well as improved patient-reported quality of life issues from the omission of surgery. Successful completion of this trial may reshape clinical practice for certain breast cancer subtypes and lead to a safe and less invasive approach for selected patients. Trial Registration ClinicalTrials.gov Identifier: NCT05505357. Registered on August 17, 2022. Clinical Research Information Service Identifier: KCT0007638. Registered on July 25, 2022.
키워드
BiopsyBreast NeoplasmsClinical TrialMulticenter StudyNeoadjuvant TherapyCANCERCHEMOTHERAPY
식별자
- Scopus EID
- 2-s2.0-85195458478
- WoS UID
- 001277783700005
- KCI
- ART003054339



로그인
연구물 목록으로